Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Polyomavirus and related diseases, and Bacteriophages and microbial interactions.
Clinical Validation of MyProstateScore 2.0 Testing Using First-Catch, Non–Digital Rectal Examination Urine
Genome-scale CRISPR screens identify PTGES3 as a direct modulator of androgen receptor function in advanced prostate cancer
A simplified MyProstateScore2.0 for high-grade prostate cancer
Caregiver burden associated with caring for individuals with tuberous sclerosis complex-associated seizures: A descriptive, non-interventional survey in Sweden
Burden of illness in tuberous sclerosis complex-associated epilepsy: a systematic literature review of epidemiology, health-related quality of life, costs and resource use
Development and Validation of an 18-Gene Urine Test for High-Grade Prostate Cancer
Cost-Utility Analysis of Add-on Cannabidiol vs Usual Care Alone for the Treatment of Seizures in Patients With Treatment-Resistant Lennox-Gastaut Syndrome or Dravet Syndrome in the Netherlands
MyProstateScore in men considering repeat biopsy: validation of a simple testing approach
Autophagy inhibition by targeting PIKfyve potentiates response to immune checkpoint blockade in prostate cancer
CD38 in Advanced Prostate Cancers
Real-World Performance of a Comprehensive Genomic Profiling Test Optimized for Small Tumor Samples
Urinary MyProstateScore (MPS) to Rule out Clinically-Significant Cancer in Men with Equivocal (PI-RADS 3) Multiparametric MRI: Addressing an Unmet Clinical Need
Genetic factors associated with prostate cancer conversion from active surveillance to treatment
Association of MyProstateScore (MPS) with prostate cancer grade in the radical prostatectomy specimen
Association of Urinary MyProstateScore, Age, and Prostate Volume in a Longitudinal Cohort of Healthy Men: Long-term Findings from the Olmsted County Study
Next-generation RNA Sequencing–based Biomarker Characterization of Chromophobe Renal Cell Carcinoma and Related Oncocytic Neoplasms
The role of the histone H3 variant CENPA in prostate cancer
Use of the MyProstateScore Test to Rule Out Clinically Significant Cancer: Validation of a Straightforward Clinical Testing Approach
Impact of the MyProstateScore (MPS) Test on the Clinical Decision to Undergo Prostate Biopsy: Results From a Contemporary Academic Practice
Characterization of glycine‐<i>N</i>‐acyltransferase like 1 (GLYATL1) in prostate cancer
NMR-Based Metabolomic Profiling of Urine: Evaluation for Application in Prostate Cancer Detection
Plasmacytoid urothelial carcinoma: a rapid autopsy case report with unique clinicopathologic and genomic profile
Expression and role of PAICS, a de novo purine biosynthetic gene in prostate cancer
VSTM2A Overexpression Is a Sensitive and Specific Biomarker for Mucinous Tubular and Spindle Cell Carcinoma (MTSCC) of the Kidney
Association of ERG/PTEN status with biochemical recurrence after radical prostatectomy for clinically localized prostate cancer
Nerve Growth Factor and Selected Cytokines in Women With and Without Vulvodynia
Integrative clinical genomics of metastatic cancer
Association Between Combined <i>TMPRSS2:ERG</i> and <i>PCA3</i> RNA Urinary Testing and Detection of Aggressive Prostate Cancer
Detection of 6 TFEB-amplified renal cell carcinomas and 25 renal cell carcinomas with MITF translocations: systematic morphologic analysis of 85 cases evaluated by clinical TFE3 and TFEB FISH assays
The utility of SDHB and FH immunohistochemistry in patients evaluated for hereditary paraganglioma-pheochromocytoma syndromes